InvestorsHub Logo
Followers 556
Posts 17586
Boards Moderated 4
Alias Born 01/02/2005

Re: None

Wednesday, 08/12/2015 10:01:02 AM

Wednesday, August 12, 2015 10:01:02 AM

Post# of 275591
RX.V / BIOYF is in with another good quarter. There was a timing issue of a large $628K international order that made Q2 a little light but Q3 looks to be stellar. June and July were both $1.5M revenue months. Also, remember that Q3 is seasonally stronger for insecticide sales. I'm expecting the 2015 EPS estimate for the one analyst of $0.28 to be exceeded. The stock is trading up slightly on the report.

http://finance.yahoo.com/news/biosyent-releases-first-six-months-120000033.html

The SwingTrade Portfolio was up 36.2% in 2014, 83.5% in 2013, and 510.9% since inception.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=109534893

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.